Lipoprotein lipase (LPL) Mouse Monoclonal Antibody [Clone ID: OTI2G8]
CAT#: TA503790
LPL (Lipoprotein lipase) mouse monoclonal antibody, clone OTI2G8 (formerly 2G8)
Size: 30 ul
Formulation: Carrier Free
Specifications
Product Data | |
Clone Name | OTI2G8 |
Applications | WB |
Recommended Dilution | WB 1:2000 |
Reactivities | Human, Mouse, Rat |
Host | Mouse |
Isotype | IgG1 |
Clonality | Monoclonal |
Immunogen | Human recombinant protein fragment corresponding to amino acids 28-475 of human LPL(NP_000228) produced in E.coli. |
Formulation | PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 1 mg/ml |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage | Store at -20°C as received. |
Stability | Stable for 12 months from date of receipt. |
Predicted Protein Size | 50.3 kDa |
Gene Name | lipoprotein lipase |
Database Link | |
Background | LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq] |
Synonyms | HDLCQ11; LIPD |
Reference Data | |
Protein Families | Druggable Genome |
Protein Pathways | Alzheimer's disease, Glycerolipid metabolism, PPAR signaling pathway |
Documents
Product Manuals |
FAQs |
Resources
Antibody Resources |
{0} Product Review(s)
Be the first one to submit a review